JP2019504895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019504895A5 JP2019504895A5 JP2018560744A JP2018560744A JP2019504895A5 JP 2019504895 A5 JP2019504895 A5 JP 2019504895A5 JP 2018560744 A JP2018560744 A JP 2018560744A JP 2018560744 A JP2018560744 A JP 2018560744A JP 2019504895 A5 JP2019504895 A5 JP 2019504895A5
- Authority
- JP
- Japan
- Prior art keywords
- biodegradable particles
- composition according
- composition
- encapsulated
- cedar pollen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002245 particle Substances 0.000 claims 15
- 239000000203 mixture Substances 0.000 claims 14
- 241000218645 Cedrus Species 0.000 claims 8
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 229920000954 Polyglycolide Polymers 0.000 claims 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims 3
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 3
- 230000000890 antigenic effect Effects 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 108020001507 fusion proteins Proteins 0.000 claims 2
- 102000037865 fusion proteins Human genes 0.000 claims 2
- 229920001610 polycaprolactone Polymers 0.000 claims 2
- 239000004632 polycaprolactone Substances 0.000 claims 2
- 239000004633 polyglycolic acid Substances 0.000 claims 2
- 239000004626 polylactic acid Substances 0.000 claims 2
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- 108091005804 Peptidases Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 206010048908 Seasonal allergy Diseases 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 201000004338 pollen allergy Diseases 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022059997A JP2022101576A (ja) | 2016-02-09 | 2022-03-31 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
| JP2025001876A JP2025069142A (ja) | 2016-02-09 | 2025-01-06 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662293261P | 2016-02-09 | 2016-02-09 | |
| US62/293,261 | 2016-02-09 | ||
| PCT/US2017/017248 WO2017139498A1 (en) | 2016-02-09 | 2017-02-09 | Timps encapsulating japanese cedar pollen epitopes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022059997A Division JP2022101576A (ja) | 2016-02-09 | 2022-03-31 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019504895A JP2019504895A (ja) | 2019-02-21 |
| JP2019504895A5 true JP2019504895A5 (enExample) | 2020-03-19 |
Family
ID=59563413
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560744A Pending JP2019504895A (ja) | 2016-02-09 | 2017-02-09 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
| JP2022059997A Pending JP2022101576A (ja) | 2016-02-09 | 2022-03-31 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
| JP2025001876A Pending JP2025069142A (ja) | 2016-02-09 | 2025-01-06 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022059997A Pending JP2022101576A (ja) | 2016-02-09 | 2022-03-31 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
| JP2025001876A Pending JP2025069142A (ja) | 2016-02-09 | 2025-01-06 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
Country Status (3)
| Country | Link |
|---|---|
| JP (3) | JP2019504895A (enExample) |
| KR (1) | KR20180105243A (enExample) |
| WO (1) | WO2017139498A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011289579B2 (en) | 2010-08-10 | 2016-11-17 | Ecole Polytechnique Federale De Lausanne | Erythrocyte-binding therapeutics |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| EP3760223A1 (en) | 2013-04-03 | 2021-01-06 | N-Fold Llc | Nanoparticle composition for desensitizing a subject to peanut allergens |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| LT3107563T (lt) | 2014-02-21 | 2021-07-12 | Ecole Polytechnique Fédérale De Lausanne (Epfl) Epfl-Tto | Gliko-nukreipiantys terapiniai agenai |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US20190365656A1 (en) * | 2016-01-04 | 2019-12-05 | Cour Pharmaceuticals Development Company, Inc. | Particles encapsulating fusion proteins containing linked epitopes |
| US11253579B2 (en) | 2017-06-16 | 2022-02-22 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| EA202092723A1 (ru) | 2018-05-09 | 2021-04-09 | Зе Юниверсити Оф Чикаго | Композиции и способы, касающиеся иммунной толерантности |
| MX2020012649A (es) * | 2018-05-25 | 2021-07-02 | The Wistar Inst | Neoantígenos especificos de tumor y métodos de uso de estos. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2007024026A1 (ja) * | 2005-08-25 | 2009-03-05 | 明石 満 | Ｔ細胞認識エピトープペプチドを固定化又は内包化した生分解性ナノ粒子 |
| WO2012174160A1 (en) * | 2011-06-14 | 2012-12-20 | The United States Of America , As Represented By The Secretary, Department Of Health And Human Services | Tem8 antibodies, conjugates thereof, and their use |
| JP6553033B2 (ja) * | 2013-08-13 | 2019-07-31 | ノースウェスタン ユニバーシティ | ペプチドコンジュゲート粒子 |
-
2017
- 2017-02-09 JP JP2018560744A patent/JP2019504895A/ja active Pending
- 2017-02-09 WO PCT/US2017/017248 patent/WO2017139498A1/en not_active Ceased
- 2017-02-09 KR KR1020187025977A patent/KR20180105243A/ko not_active Ceased
-
2022
- 2022-03-31 JP JP2022059997A patent/JP2022101576A/ja active Pending
-
2025
- 2025-01-06 JP JP2025001876A patent/JP2025069142A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019504895A5 (enExample) | ||
| RU2016107998A (ru) | Частицы, конъюгированные с пептидом | |
| Acar et al. | Self-assembling peptide-based building blocks in medical applications | |
| JP2016511747A5 (enExample) | ||
| Grego et al. | Polymeric nanoparticle-based vaccine adjuvants and delivery vehicles | |
| Lee et al. | Biodegradable viral nanoparticle/polymer implants prepared via melt-processing | |
| Pavot et al. | Poly (lactic acid) and poly (lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery | |
| Oyewumi et al. | Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses | |
| RU2014124682A (ru) | Полимерные белковые микрочастицы | |
| JP2019507113A5 (enExample) | ||
| Rauta et al. | Parenteral immunization of PLA/PLGA nanoparticle encapsulating outer membrane protein (Omp) from Aeromonas hydrophila: Evaluation of immunostimulatory action in Labeo rohita (rohu) | |
| JP2014533698A5 (enExample) | ||
| JP2017538672A5 (enExample) | ||
| JP2016509011A5 (enExample) | ||
| Mishra et al. | Biodegradable polymer based particulate carrier (s) for the delivery of proteins and peptides | |
| KR20160003212A (ko) | 면역 관용의 유도를 위한 특정된 약역학적 유효 수명을 갖는 면역억제제 및 항원의 전달 | |
| CN114306638A (zh) | 从合成纳米载体中控制释放免疫抑制剂 | |
| JP2016519933A5 (enExample) | ||
| JP2017524682A5 (enExample) | ||
| Craparo et al. | Application of polymeric nanoparticles in immunotherapy | |
| JP2016521712A5 (enExample) | ||
| JP2021502807A5 (enExample) | ||
| JP2009520758A5 (enExample) | ||
| Gláucia-Silva et al. | A biotechnological approach to immunotherapy: Antivenom against Crotalus durissus cascavella snake venom produced from biodegradable nanoparticles | |
| Kaur et al. | Recent advances on biodegradable polymeric carrier-based mucosal immunization: an overview |